SweetBio

SweetBio, Inc. is an FDA-cleared medical device company specializing in advanced wound care dressings that combine collagen, certified Mānuka honey, and hydroxyapatite for accelerated healing of acute and chronic wounds. The company manufactures two primary product lines: VERIS™, a quick-dissolve daily dressing, and APIS®, a slow-dissolve weekly cellular therapy product/skin substitute. Both products are clinically proven to reduce time to wound closure compared to standard of care, with Medicare and commercial insurance reimbursement. SweetBio's formulations demonstrate significant efficacy in reducing bacterial burden (99.99% reduction of S. aureus and P. aeruginosa), controlling inflammatory markers (MMP-9 suppression), and promoting pro-regenerative growth factors. The technology is backed by multiple peer-reviewed publications in dermatologic surgery, wound healing, and biomaterials journals, including RCTs and clinical case series from institutions such as Vanderbilt University Medical Center. SweetBio operates from the University of Memphis CommuniTech Research Park with a mission to make advanced wound care accessible and affordable.